Executive Summary
The 2026-11-05/06 overnight SEC filing window is dominated by M&A and corporate-structure events rather than operating results: the $1.8B-profit-pool Array Technologies/Shoals Technologies all-stock merger (Shoals holders to own ~65% of the combined company, closing targeted Q1 2027) and the Sylvamo put-option agreement to divest its Europe business (closing targeted end-Q1 2027) are the highest-materiality items, alongside X Financial's $6.03/ADS management buyout proposal from a 93.45%-voting-power chairman.
Operating results were mixed: Chunghwa Telecom delivered a standout Q3 (revenue +16.7% YoY, net income +29.5% YoY, above high-end guidance) while United Breweries grew 9M sales 6.4% but saw net income fall 22.9% on a shrinking tax benefit, and Marten Transport's Q3 net income rose 30.7% YoY yet 9M net income fell 29.9% with its Intermodal segment fully discontinued. Insider activity skewed negative in size: MediaAlpha's White Mountains sold 5.5M shares for ~$76.5M (stake down to ~24.27%, 30-day lock-up), ADMA's CEO sold 105,000 shares for ~$1.26M under a 10b5-1 plan, and Ryerson's CEO sold ~$686K, partially offset by a Metallus director buying ~$166K. Credit and capital-markets actions were constructive: EVERTEC repriced ~$388M Term Loan A and its revolver 25 bps lower while upsizing the revolver to $300M, and HSBC upsized its CoCo tender by 50% to $1.5B. The SPAC/IPO pipeline remains active but fragile, with Starry Sea extending its deadline by one month via a $60K affiliate loan, K&F Growth extending its completion window to August 2027, and Constellation Acquisition's S-4 going effective subject to a $14M minimum cash condition.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Schedule 13D · Schedule 13G · Form 4 · 425 · S-1 · 13F · 10-Q · 8-K
Tracking the trend? Catch up on the prior US Pre-Market SEC Filings Roundup digest from November 05, 2026.
Investment Signals (13)
- ▲
All-stock merger with Shoals holders receiving 1.6931 ARRY shares and owning ~65% of the combined company; >$20M annual cost savings, ~$1.8B US profit pool, $161.3M preferred redemption within 90 days of closing and $156.3M more over three years (>60% of preferred retired), pro forma 2026 net debt/EBITDA 2.6x falling below 2x in 2027
- Chunghwa Telecom ↓ (BULLISH)▲
Q3 2026 revenue +16.7% YoY to NT$67.59B, operating income +27.1%, net income +29.5% to NT$12.22B (EPS NT$1.57), all above the high end of guidance — the strongest period-over-period print in the window
- EVERTEC ↓ (BULLISH)▲
Amended credit agreement reprices ~$388M Term Loan A and the revolver 25 bps lower, extends maturities up to five years, and upsizes the revolver from $200M to $300M — direct EPS-accretive interest savings with Truist as agent
- Metallus ↓ (BULLISH)▲
Director Ronald A. Rice bought 10,000 shares at $16.61 (~$166K), lifting his holding to 161,818 shares — the largest open-market insider purchase in the window
- Grace Therapeutics ↓ (BULLISH)▲
10% owner Opaleye Management added 18,442 shares across three prints at $1.77–$1.80 (~$33K), raising its stake to 3,054,853 shares — small but consistent accumulation by a specialist holder
- HSBC Holdings ↓ (BULLISH)▲
Upsized its 6.000% perpetual subordinated CoCo tender by 50%, from $1.0B to $1.5B aggregate principal, launched Nov 5 — signals balance-sheet optimization and confidence in capital ratios
- Sylvamo ↓ (BULLISH)▲
Put option agreement with Midas Atlantic Partners (with The Najafi Companies) for a binding offer on its Europe business, retaining a right to 20% of future distributions; closing targeted end-Q1 2027 — portfolio simplification catalyst
- X Financial ↓ (BULLISH)▲
Chairman/CEO Yue (Justin) Tang's Mangrove Coast proposed $1.005/ordinary share ($6.03/ADS) to acquire the public float while already holding ~93.45% of voting power; special committee to be formed — take-private premium catalyst
- Tampa Electric ↓ (BULLISH)▲
9M 2026 net income +2.9% to $537M on revenue +6.1% to $2,557M, operating cash flow +69.5% to $1,071M, Q3 O&M down 26.9% to $163M — cash generation inflecting despite Q3 net income -1.4%
- Castellum ↓ (BULLISH)▲
Debt-free with $15.7M cash and $24.5M cash plus receivables; qualified opportunity pipeline surged to ~$1.662B from $953.5M, even as backlog slipped to $254.5M from $271.7M at June 30
- MediaAlpha ↓ (BEARISH)▲
White Mountains sold 5,500,391 Class A shares at $13.90 (~$76.5M) under Rule 144, cutting beneficial ownership to ~24.27%, with a 30-day J.P. Morgan lock-up on further sales — overhang now quantified and time-boxed
- ADMA Biologics ↓ (BEARISH)▲
President/CEO Adam Grossman sold 105,000 shares at $12.00 (~$1.26M) after exercising at $5.40, plus a separate 42,000-share sale (~$504K), all under a Rule 10b5-1 plan; retains 2,070,777 shares
- Ryerson Holding ↓ (BEARISH)▲
CEO Edward Lehner sold 21,968 shares at $31.22 (~$686K), leaving 623,596 shares — a meaningful discretionary-looking sale at the top of the recent range
Risk Flags (10)
- United Breweries (CCU) [HIGH RISK]▼
9M 2026 net income fell 22.9% YoY to ThCh$54.74B (EPS Ch$133.73 vs Ch$167.94) despite sales +6.4%, as the income tax benefit shrank to ThCh$4.90B from ThCh$44.98B and finance income dropped 42.2%; distribution costs +8.3% and admin costs +9.4% both outpaced sales — Q3 net income -21.8% YoY
- Marten Transport↓ [HIGH RISK]▼
9M 2026 revenue -3.4% to $650.3M, net income -29.9% to $9.6M, operating income -36.9% to $11.6M; Q3 operating ratio 98.6% with Truckload at 100.2% (operating loss of $0.2M) and Dedicated operating income -63.6%; Intermodal fully discontinued (zero revenue vs $9.9M)
- Castellum↓ [HIGH RISK]▼
Q3 gross margin compressed to 36% from 38% YoY on lower-margin subcontractor mix, Adjusted EBITDA fell to ~$0.6M from $1.1M, and the company swung to a $(0.5)M net loss from $0.4M income; backlog of $254.5M is only $18.2M funded ($236.3M unfunded)
- MediaAlpha↓ [MEDIUM RISK]▼
White Mountains' ~$76.5M block sale at $13.90 leaves a ~24.27% overhang and a 30-day lock-up; further distribution after the lock-up lapses is a structural supply risk
- ADMA Biologics↓ [MEDIUM RISK]▼
CEO sold ~$1.26M plus ~$504K in shares at $12.00 following a $5.40 exercise — even under 10b5-1, the pace of sales against a 2.07M-share residual holding warrants monitoring
- NovaBridge Biosciences↓ [MEDIUM RISK]▼
HHLR Advisors and Hillhouse filed a final exit 13D/A at 4.9% ownership, selling 200,000 ADSs at $1.01 on Nov 5 — sponsor fully departing below the 5% threshold
- Constellation Acquisition Corp I↓ [MEDIUM RISK]▼
S-4 declared effective but the deal remains subject to a $14M minimum cash condition, shareholder approval and Nasdaq listing; PIPE is only ~$20M–$30M with a $4.0M sponsor-affiliate commitment — financing gap risk if redemptions spike
- Passage BIO / Remix Therapeutics↓ [MEDIUM RISK]▼
All merger proposals passed, but the 2026 Equity Incentive Plan drew ~458,604 votes against (~25% of votes cast) and the ESPP passed with only 1,383,770 for vs 458,604 against; charter governance changes saw ~355K–363K opposition — shareholder dissent to watch post-close
- Starry Sea Acquisition Corp↓ [MEDIUM RISK]▼
Needed a $60K affiliate loan from merger target SuperiorMed to extend its deadline one month to Dec 7, 2026; F-4/S-4 still to be filed and declared effective — timeline slippage risk
- Tampa Electric↓ [MEDIUM RISK]▼
Q3 2026 net income -1.4% to $217M on revenue -3.0% to $893M as fuel expense jumped 35.8% to $205M and interest expense rose to $62M from $59M — fuel and rate-case cost recovery is the swing factor
Opportunities (10)
- ◆
1.6931 exchange ratio with Shoals holders owning ~65% of the combined entity, >$20M cost savings, Shoals' ~$1.6B tax amortization and $237M NOLs, and deleveraging from 2.6x to <2x net debt/EBITDA by 2027 — spread opportunity into the Q1 2027 close pending both shareholder votes
- X Financial take-private↓ (OPPORTUNITY)◆
$6.03/ADS proposal from a chairman holding ~93.45% of voting power implies a squeeze-out of a thin float; special committee formation and any revised proposal are near-term catalysts
- Sylvamo Europe divestiture (OPPORTUNITY)◆
Put option with Midas Atlantic Partners/Najafi plus a 20% future-distribution participation right converts a cyclical European paper business into a royalty-like stream; definitive SPA and works-council consultation by end-Q1 2027
- EVERTEC refinancing (OPPORTUNITY)◆
25 bps repricing on ~$388M Term Loan A plus revolver upsized to $300M and extended — modest but certain EPS accretion and added liquidity for tuck-in M&A
- Chunghwa Telecom momentum (OPPORTUNITY)◆
Q3 beat across revenue, operating income and net income with EPS NT$1.57; watch whether the 16.7% revenue growth and 29.5% profit growth carry into Q4 guidance, though EBITDA margin slipped to 37.97% from 38.17%
- Tampa Electric cash-flow inflection (OPPORTUNITY)◆
9M operating cash flow +69.5% to $1,071M and Q3 O&M -26.9% to $163M; if fuel expense normalizes, the Q3 net income dip (-1.4%) looks transient
- Castellum pipeline conversion (OPPORTUNITY)◆
~$1.662B qualified opportunity pipeline (up from $953.5M) against a $254.5M backlog and a debt-free balance sheet with $15.7M cash — contract awards would be highly accretive to a small-cap base
- HSBC CoCo tender (OPPORTUNITY)◆
Upsized to $1.5B at 6.000% callable May 22, 2027 — holders can exit at tender terms while HSBC optimizes its AT1 stack; watch final participation results
- K&F Growth Acquisition Corp. II↓ (OPPORTUNITY)◆
Completion window extended to August 6, 2027 (30 months post-IPO) — removes near-term redemption pressure and buys time for a deal announcement
- Metallus insider signal (OPPORTUNITY)◆
Director purchase of 10,000 shares at $16.61 (~$166K) is the largest open-market buy in the window and aligns with a cyclical steel recovery thesis
Sector Themes (6)
- Solar/clean-energy consolidation◆
The Array/Shoals stock-for-stock merger (Shoals holders ~65%, >$20M synergies, ~$1.8B US profit pool, only 20% project overlap) plus Constellation's McDermitt lithium S-4 effectiveness show SPAC and strategic consolidation accelerating in energy transition — expect more all-stock deals structured to avoid refinancing existing debt [IMPLICATION: favor acquirers with tax attributes and deleveraging paths]
- Industrial/transport margin pressure◆
Marten Transport (9M operating income -36.9%, Truckload OR 100.2%) and Castellum (gross margin 36% vs 38%, Adjusted EBITDA halved) both show cost inflation and mix shift compressing margins despite flat-to-modest revenue growth — a broad industrial caution flag [IMPLICATION: margin, not volume, is the 2027 earnings swing factor]
- Insider selling skew in small/mid-cap healthcare and media◆
MediaAlpha (~$76.5M White Mountains block), ADMA (~$1.26M CEO sale) and Ryerson (~$686K CEO sale) versus only Metallus (~$166K) and Grace Therapeutics (~$33K) of buying — a 10:1 dollar-weighted sell/buy ratio in this window [IMPLICATION: supply overhang in sponsor-backed names]
- Constructive corporate credit actions◆
EVERTEC (25 bps repricing, revolver upsized to $300M) and HSBC (CoCo tender upsized 50% to $1.5B) both point to improving refinancing conditions and proactive liability management [IMPLICATION: credit spreads supportive for IG issuers into year-end]
- SPAC deadline extensions and financing strain◆
Starry Sea ($60K affiliate loan to extend to Dec 7, 2026), K&F Growth (window to Aug 6, 2027) and Constellation ($14M minimum cash condition) show blank-check vehicles still dependent on sponsor/target funding to survive — deal-completion risk remains elevated [IMPLICATION: discount SPAC arbitrage spreads for extension risk]
- Foreign private issuer 6-K cluster◆
15+ 6-K filings (Allied Gold, Aya Gold & Silver, B2Gold, Gold Royalty, IsoEnergy, OceanaGold, Taseko, Sun Life, NetEase, Chunghwa) with Q3/9M results attached as exhibits — mining and telecom reporting season is in full flow, with Chunghwa the only quantified standout [IMPLICATION: read exhibits for the miners; wrapper filings carry no data]
Watch List (8)
-
Shareholder votes on both sides and regulatory approvals for the Q1 2027 close; watch the new corporate name/ticker announcement and any revised synergy guidance [Q1 2027]
-
Special committee formation and any revised Mangrove Coast proposal above $6.03/ADS; board recusal of Chairman Tang confirmed [near-term]
- 👁
Works-council and employee-representative consultations, then definitive share purchase agreement for the Europe business; closing targeted end-Q1 2027 [Q1 2027]
-
$14M minimum cash condition and PIPE sizing (~$20M–$30M) ahead of the Q4 2026 target close; Nasdaq listing approval for 'ULIT' [Q4 2026]
-
Form F-4/S-4 filing and effectiveness before the Dec 7, 2026 extended deadline; further affiliate loans would signal stress [Dec 7, 2026]
-
30-day J.P. Morgan lock-up expiry on White Mountains' remaining ~24.27% stake — potential follow-on block supply [early December 2026]
-
Post-vote integration, reverse split ratio (1-for-2 to 1-for-10) execution and renaming; monitor dissent (~25% against equity plan) for governance friction [post-close]
-
Q4 2026 guidance and whether the 16.7% Q3 revenue growth is sustainable given the Enterprise Business Group's 3.1% pre-tax income decline and the one-off ICT comparison base [next quarterly report]
Filing Analyses
(50)
05-11-2026
White Mountains Insurance Group and its subsidiary WM Hinson sold 5,500,391 Class A shares of MediaAlpha to J.P. Morgan Securities LLC at $13.90 per share on November 4, 2026, pursuant to Rule 144, generating approximately $76.5M in gross proceeds. Following the sale, the Reporting Persons' beneficial ownership fell to approximately 24.27% of Class A shares (12,356,223 shares), down from the prior 11,456,223 shares held indirectly plus 900,000 directly. The sale was intended to monetize a portion of their stake, and the Reporting Persons are now subject to a 30-day lock-up with J.P. Morgan restricting further transfers.
- · Sale executed on November 4, 2026, disclosed in Amendment No. 8 to Schedule 13D filed June 30, 2023
- · White Mountains directly holds 900,000 Class A shares; WM Hinson holds 11,456,223 Class A shares
- · Reporting Persons hold no Class B shares
- · Robert L. Seelig holds 10,000 Class A shares; John G. Sinkus holds 750 Class A shares
- · Ownership percentages based on 50,903,805 Class A shares outstanding as of October 26, 2026 (per Form 10-Q filed October 28, 2026)
- · Reporting Persons subject to a 30-day lock-up with J.P. Morgan Securities LLC restricting transfers, subject to certain exceptions
05-11-2026
Integrated Core Strategies (US) LLC, together with Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander, filed a Schedule 13G/A disclosing beneficial ownership of Longeveron Inc. Class A Common Stock as of September 30, 2026. All reporting persons report 0.00 shares and 0.0% ownership across every cover-page item, indicating the stake has been fully exited or reduced to zero. The filing is a passive-holder disclosure under Rule 13d-1(c) with no intent to influence control.
- · Event date of ownership change: September 30, 2026
- · CUSIP: 54303L302
- · Filing made under Rule 13d-1(c) (passive investor exemption)
- · Joint Filing Agreement dated November 4, 2026
- · Longeveron is a Delaware-incorporated pharmaceutical preparations company (SIC 2834) headquartered in Miami, Florida
- · Filing persons certify securities were not acquired for the purpose of changing or influencing control of the issuer
05-11-2026
Director ALEXANDER PATRICK L sold 3,018 Common Stock at $32.50 (~$98.1K). ALEXANDER PATRICK L holds 67,093 shares after the transaction.
- · Director ALEXANDER PATRICK L was awarded 695 Common Stock
- · Director ALEXANDER PATRICK L sold 3,018 Common Stock at $32.50 (~$98.1K)
- · Director ALEXANDER PATRICK L sold 350 Common Stock at $32.50 (~$11.4K)
05-11-2026
10% owner Opaleye Management Inc. bought 10,328 Common Stock, par value $0.0001 per share at $1.79 (~$18.5K). Opaleye Management Inc. holds 3,054,853 shares after the transaction.
- · 10% owner Opaleye Management Inc. bought 10,328 Common Stock, par value $0.0001 per share at $1.79 (~$18.5K)
- · 10% owner Opaleye Management Inc. bought 5,027 Common Stock, par value $0.0001 per share at $1.80 (~$9.06K)
- · 10% owner Opaleye Management Inc. bought 3,087 Common Stock, par value $0.0001 per share at $1.77 (~$5.48K)
05-11-2026
President and CEO Grossman Adam S sold 105,000 Common Stock at $12.00 (~$1.26M). 4 transactions reported in total. Grossman Adam S holds 2,070,777 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · President and CEO Grossman Adam S exercised/converted 105,000 Common Stock at $5.40 (~$567K)
- · President and CEO Grossman Adam S sold 105,000 Common Stock at $12.00 (~$1.26M)
- · President and CEO Grossman Adam S sold 42,000 Common Stock at $12.00 (~$504K)
- · President and CEO Grossman Adam S exercised/converted 105,000 Stock Option (Right to Buy)
05-11-2026
10% owner WHITE MOUNTAINS INSURANCE GROUP LTD sold 5,500,391 Class A Common Stock at $13.90 (~$76.5M). WHITE MOUNTAINS INSURANCE GROUP LTD holds 12,356,223 shares after the transaction.
- · 10% owner WHITE MOUNTAINS INSURANCE GROUP LTD sold 5,500,391 Class A Common Stock at $13.90 (~$76.5M)
05-11-2026
Director RICE RONALD A bought 10,000 Common Shares at $16.61 (~$166K). RICE RONALD A holds 161,818 shares after the transaction.
- · Director RICE RONALD A bought 10,000 Common Shares at $16.61 (~$166K)
05-11-2026
MetLife filed a Schedule 13D/A disclosing that its Board of Directors, as an entity, beneficially owns 100,527,578 shares (16.0% of outstanding Common Stock) held by the MetLife Policyholder Trust as of October 30, 2026. The share count declined from 102,098,469 to 100,527,578 since July 31, 2026, continuing a long-term reduction from the 494,466,664 shares originally issued to the Trust in April 2000. The Board's deemed beneficial ownership stems from its ability to direct voting of Trust shares on certain matters, not from any new purchase or acquisition.
- · No transactions in the reported securities were effected by the Reporting Persons since July 31, 2026 other than the decrease in Trust shares.
- · The Trustee votes Trust shares per Board recommendation on ordinary matters, but on Beneficiary Consent Matters votes in the same ratio as Beneficiary instructions.
- · Beneficiaries may instruct the Custodian to withdraw allocated shares to participate in tender/exchange offers or mergers.
- · MetLife does not currently have a stockholder rights plan.
- · The Board has shared voting power over the 100,527,578 shares; Beneficiaries hold economic rights to dividends and sale proceeds.
- · Filing includes Exhibit 99.1 Joint Filing Agreement under Rule 13d-1(k)(1).
05-11-2026
Director Joseph Fred J. had withheld for taxes 652 Common Stock at $37.49 (~$24.4K). This amends a previously filed Form 4. Joseph Fred J. holds 26,990 shares after the transaction.
- · Director Joseph Fred J. had withheld for taxes 652 Common Stock at $37.49 (~$24.4K)
05-11-2026
Director Spring Maria F had withheld for taxes 583 Common Stock at $37.49 (~$21.9K). This amends a previously filed Form 4. Spring Maria F holds 36,574 shares after the transaction.
- · Director Spring Maria F had withheld for taxes 583 Common Stock at $37.49 (~$21.9K)
05-11-2026
HHLR Advisors, Ltd. and Hillhouse Investment Management, Ltd. filed Amendment No. 6 to their Schedule 13D, an exit filing marking the termination of their reporting obligations for NovaBridge Biosciences. The two entities collectively beneficially own 13,295,306 Ordinary Shares (via 5,780,568 ADSs), representing 4.9% of the 270,740,383 Ordinary Shares outstanding as of July 27, 2026 — a stake that has fallen below the 5% threshold. The filing discloses a single recent transaction: a sale of 200,000 ADSs on November 5, 2026 at $1.01 per ADS.
- · Each 10 ADSs represents 23 Ordinary Shares.
- · This Amendment No. 6 is the final amendment and constitutes an 'exit filing' for each Reporting Person.
- · HHLR and HIM are under common control and share certain policies, personnel and resources.
- · Prior amendments were filed on September 14, 2020; December 21, 2021; March 25, 2021; June 24, 2021; September 27, 2021; and June 30, 2023.
- · No CUSIP number is assigned to the Ordinary Shares; CUSIP 44975P103 applies to the ADSs.
- · The issuer was formerly named I-Mab (name change dated May 28, 2019).
05-11-2026
Director Dean Robert E had withheld for taxes 551 Common Stock at $37.49 (~$20.7K). This amends a previously filed Form 4. Dean Robert E holds 34,987 shares after the transaction.
- · Director Dean Robert E had withheld for taxes 551 Common Stock at $37.49 (~$20.7K)
05-11-2026
Director Gallotta Steven E. bought 55 Common Stock at $9.13 (~$502). This amends a previously filed Form 4. Gallotta Steven E. holds 1,514 shares after the transaction.
- · Director Gallotta Steven E. bought 55 Common Stock at $9.13 (~$502)
05-11-2026
CEO Lehner Edward J. sold 21,968 Common Stock (par value $0.01 per share) at $31.22 (~$686K). Lehner Edward J. holds 623,596.4833 shares after the transaction.
- · CEO Lehner Edward J. sold 21,968 Common Stock (par value $0.01 per share) at $31.22 (~$686K)
05-11-2026
Director Kim Denny bought 57 Common Stock at $8.79 (~$501). This amends a previously filed Form 4. Kim Denny holds 1,516 shares after the transaction.
- · Director Kim Denny bought 57 Common Stock at $8.79 (~$501)
05-11-2026
Array Technologies and Shoals Technologies Group announced a stock-for-stock merger in which Array is the legal acquirer and surviving entity, with each Shoals share exchanged for 1.6931 Array shares; Shoals shareholders will own approximately 65% of the combined company and Array shareholders 35%. The companies expect more than $20 million in annual cost savings from eliminating duplicate public company costs and cite a ~$1.8 billion annual US profit pool, but only 20% of solar projects currently use products from both companies, and the deal remains subject to shareholder and regulatory approvals with closing targeted for Q1 2027. The combined company plans to redeem $161.3 million of preferred stock within 90 days of closing and an additional $156.3 million over three years, reducing preferred outstanding by over 60%, while carrying pro forma 2026 net debt to EBITDA of 2.6x (below 2x expected in 2027).
- · Transaction structured to avoid refinancing Array's existing debt, preserving attractive financing and reducing execution risk
- · All shares exchanged for Array common stock at closing; Array share price will reflect combined business thereafter
- · New corporate name and ticker symbol to be announced in coming months
- · Registration statement and joint proxy statement/prospectus expected to be filed with SEC in coming weeks
- · Combined company will supply essentially all key sBOS and EBOS components for utility-scale solar projects
- · Potential product innovations include tracker torque tubes with integrated attachment points for Shoals BLA, integrated wire management, pre-engineered kits, and digital design tools
- · Deal requires majority approval of both Array and Shoals shareholders plus regulatory approvals
05-11-2026
The SEC declared effective US Elemental Inc.'s Form S-4 registration statement for its proposed business combination with Constellation Acquisition Corp I, a key procedural step toward listing McDermitt lithium assets on Nasdaq under ticker "ULIT" with Jindalee expected to retain 80%+ ownership. The deal contemplates a PIPE financing of approximately $20M-$30M, including a binding $4.0M commitment from a Constellation sponsor affiliate ($1.5M already funded, $2.5M at closing), but remains subject to a $14M minimum cash condition, Constellation shareholder approval, and Nasdaq listing approval. Completion is targeted for Q4 2026, though the filing cautions there can be no assurance conditions will be met or the deal completed on schedule.
- · SEC effectiveness is a procedural step and does not represent SEC approval of the Business Combination
- · Jindalee shareholder approval for the Business Combination was obtained in June 2026
- · SEC review process began with initial filing in June 2026
- · PIPE term sheets from several US funds are non-binding; target may be met subject to further negotiation and definitive agreements
- · HiTech Minerals owns 100% of the McDermitt Lithium Project in southeast Oregon
- · Constellation sponsors entered a support agreement to vote their shares in favor of the Business Combination
- · Constellation trades OTCPK: CSTAF; Jindalee trades ASX: JLL, OTCQX: JNDAF
- · Remaining closing conditions include regulatory approvals and absence of material adverse change events
05-11-2026
Shoals Technologies Group and Array Technologies announced a stock-for-stock merger in which Array is the legal acquirer and surviving entity, with each Shoals share exchanged for 1.6931 Array shares; Shoals shareholders will own approximately 65% of the combined company and Array shareholders 35%. The companies expect more than $20 million in annual cost savings and cite Shoals' approximately $1.6 billion of tax amortization and $237 million of NOLs, while the combined company is projected at 2.6x net debt to EBITDA on a pro forma 2026 basis and under 2x in 2027. However, the deal requires majority approval from both shareholder bases and regulatory approvals, with closing targeted for Q1 2027, and the company plans to redeem $161.3 million of preferred stock within 90 days of closing plus an additional $156.3 million over three years to cut preferred outstanding by over 60%.
- · Transaction structured as stock-for-stock with Array as legal acquirer/surviving entity to avoid refinancing Array's existing debt
- · All shares exchanged for Array common stock at closing; Array share price to reflect combined business thereafter
- · Combined board will have 10 directors: four independent from each Shoals board, four from Array board, plus Brad Forth and Brandon Moss
- · New corporate name and ticker symbol to be announced in the coming months
- · Registration statement and joint proxy statement/prospectus expected to be filed with SEC in the coming weeks
- · Separate Q3 2026 results releases issued by each company the same morning
- · Companies did not provide reconciliations of certain non-GAAP measures (including adjusted EBITDA) due to unreasonable effort in connection with the transaction
05-11-2026
Allied Gold Corp filed a routine Form 6-K with the SEC on November 5, 2026, covering the month of November 2026, and references a press release dated November 4, 2026 as Exhibit 99.1. The filing itself contains only administrative cover-page and signature information (signed by Sofia Tsakos, Chief Legal Officer and Corporate Secretary) with no financial figures, operational metrics, or period-over-period data disclosed in the body. As a result, no positive, negative, or flat performance metrics can be assessed from this filing.
- · Registrant files annual reports under Form 40-F (not Form 20-F)
- · SEC Commission File Number: 001-42672
- · Principal executive office: Royal Bank Plaza, North Tower, 200 Bay Street, Suite 2200, Toronto, Ontario M5J 2J3
- · Filing signed November 4, 2026; report covers the month of November 2026
- · Exhibit 99.1 is a press release dated November 4, 2026 (content not included in the filing text)
05-11-2026
Aya Gold & Silver Inc. furnished a Form 6-K to the SEC on November 05, 2026, disclosing an exhibit titled 'Boumadine Drill Results Milestone' from its Boumadine project. The filing is a routine foreign private issuer report (Form 40-F filer) and contains no financial figures, production data, or period-over-period comparisons in the furnished text. The document was signed by Elias J. Elias, Chief Legal and Sustainability Officer & Corporate Secretary.
- · Filing is a Form 6-K under Rule 13a-16/15d-16 for the month of November 2026
- · Registrant files annual reports under Form 40-F (not Form 20-F)
- · SEC Commission File Number: 001-43230
- · Principal executive office located at 1320 boulevard Graham, suite 132, Mont-Royal, Quebec, Canada, H3P 3C8
- · Exhibit 99.1 'Boumadine Drill Results Milestone' is the sole exhibit filed herewith
- · Signature block dated Aug 5, 2026, which precedes the stated November 2026 filing month
05-11-2026
B2Gold Corp. filed a Form 6-K on November 5, 2026 (covering the month of November 2026), attaching a press release dated November 4, 2026 as Exhibit 99.1. The filing itself contains only cover-page and signature information (signed by Randall Chatwin, SVP Strategy and Chief Legal Officer) with no financial results, production figures, or other quantitative disclosures in the body text. No period-over-period metrics are available in the provided content.
- · Filing is a Form 6-K under Rule 13a-16/15d-16 of the Securities Exchange Act of 1934
- · Commission File Number: 001-35936
- · Registrant files annual reports under Form 40-F (not Form 20-F)
- · Jurisdiction of incorporation: British Columbia, Canada
- · Principal executive office: Suite 3400, Park Place, 666 Burrard Street, Vancouver, British Columbia V6C 2X8
- · Press release dated November 4, 2026 attached as Exhibit 99.1 (content not included in filing text)
05-11-2026
Central Puerto S.A. (CPSA) disclosed a share transaction on BYMA: 120,000 shares traded on 11/04/2026 with settlement on 11/05/2026 at an average price of AR$ 1,708.16, for a total cash amount of AR$ 204,979,814. No NYSE/ADR transaction was reported in this filing. The disclosure is a routine relevant-event notice with no stated impact on operations or financial condition.
- · Transaction executed on BYMA on 11/04/2026 with trade completion/settlement on 11/05/2026
- · No NYSE ADR transaction was reported in this filing
- · Number of shares equals equivalent number of shares (120,000), indicating no ADR conversion involved
05-11-2026
Chunghwa Telecom reported Q3 2026 total revenue up 16.7% YoY to NT$67.59 billion, with operating income up 27.1% to NT$15.38 billion and net income attributable to parent up 29.5% to NT$12.22 billion (EPS NT$1.57), all exceeding the high end of quarterly guidance. However, EBITDA margin slipped to 37.97% from 38.17% and total operating costs rose 14.0% to NT$52.21 billion, while Enterprise Business Group pre-tax income declined 3.1% on higher ICT-related and personnel costs despite 8.2% revenue growth.
- · EBITDA margin declined to 37.97% from 38.17% YoY despite EBITDA growth of 16.1%
- · Enterprise Business Group income before tax fell 3.1% YoY on higher ICT costs and seasonal personnel expenses
- · International Business Group ICT revenue declined due to high comparison base from a one-off project last year
- · Basic EPS was NT$1.57
- · Mobile post-paid ARPU excluding IoT SIMs rose 2.0% to NT$573
- · Fixed broadband ARPU rose 1.6% to NT$822
- · 5G smartphone penetration close to 50%
- · Fixed-line subscribers stood at 8.44 million
- · Revenue, profit and EPS were the highest for any third quarter since 2009
05-11-2026
Gold Royalty Corp. filed a Form 6-K on November 5, 2026, furnishing its condensed interim consolidated financial statements and MD&A for the three and nine months ended September 30, 2026, along with CEO and CFO certifications. The filing itself contains only cover-page and exhibit-index information; no specific revenue, earnings, or production figures are disclosed in the provided text, so period-over-period comparisons cannot be calculated from this excerpt.
- · Reporting period covered: three and nine months ended September 30, 2026
- · Commission File Number: 001-40099
- · Principal executive offices: 1188 West Georgia Street, Suite 1830, Vancouver, BC V6E 4A2
- · Registrant files annual reports under Form 20-F
- · Exhibits incorporated by reference into Form F-3 registration statements (File Nos. 333-280817, 333-280507, 333-276305, 333-267633, 333-270682) and Form S-8 (File No. 333-267421)
- · Exhibit 99.1: Condensed interim consolidated financial statements for the three and nine months ended September 30, 2026
- · Exhibit 99.2: Management's discussion and analysis for the three and nine months ended September 30, 2026
- · Exhibits 99.3 and 99.4: CEO and CFO certifications
- · Filing signed November 4, 2026
05-11-2026
Gold Royalty Corp. filed a Form 6-K with the SEC on November 5, 2026, disclosing a press release dated November 4, 2026 (Exhibit 99.1) signed by CFO Andrew Gubbels. The filing itself contains only cover-page and signature information with no financial figures, operational metrics, or period-over-period data disclosed in the body text.
- · Filing is a Form 6-K under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934
- · Commission File Number: 001-40099
- · Registrant files annual reports under Form 20-F (not Form 40-F)
- · Principal executive offices: 1188 West Georgia Street, Suite 1830, Vancouver, BC V6E 4A2, Canada
- · Phone: (604) 396-3066
- · Filing covers the month of November 2026; signed November 4, 2026
- · Exhibit 99.1 is a press release dated November 4, 2026 — its contents are not included in the filing text provided
05-11-2026
IsoEnergy Ltd. filed a Form 6-K on November 5, 2026 (signed November 4, 2026 by CFO Graham du Preez), incorporating by reference its Management's Discussion and Analysis and unaudited condensed consolidated interim financial statements for the three and nine months ended September 30, 2026 and 2025. The filing itself contains no financial figures, only the exhibit index and incorporation-by[redacted] language into its Form F-10 and Form S-8 registration statements. No period-over-period performance data was disclosed in the filing text.
- · Filing is a Form 6-K for the month of November 2026 under Commission File Number 001-42611
- · Registrant files annual reports under Form 40-F (not Form 20-F)
- · Exhibits incorporated by reference into Registration Statement on Form F-10 (Commission File No. 333-292714) and Form S-8 (Commission File No. 333-287876)
- · Exhibit 99.1: Management's Discussion and Analysis for the three and nine months ended September 30, 2026 and 2025
- · Exhibit 99.2: Unaudited Condensed Consolidated Interim Financial Statements for the three and nine months ended September 30, 2026 and 2025
- · Principal executive offices located at 217 Queen Street West, Suite 401, Toronto, Ontario M5V 0R2
- · Filing signed November 4, 2026
05-11-2026
OceanaGold Corporation filed a Form 6-K on November 5, 2026, incorporating its condensed interim consolidated financial statements and MD&A for the three and nine months ended September 30, 2026, along with CEO/CFO certifications and a November 4, 2026 news release. The filing itself is a cover document that references the attached exhibits but does not disclose specific financial figures, revenue, production, or period-over-period comparisons in the provided text. No quantitative performance data is available in this excerpt to assess positive, negative, or flat trends.
- · Filing is a Form 6-K for the month of November 2026 under Commission File Number 001-43215
- · Registrant files annual reports under Form 40-F (not Form 20-F)
- · Exhibits 99.1 and 99.2 are incorporated by reference into Registration Statement on Form S-8 (File No. 333-294905)
- · Exhibit 99.1: Condensed Interim Consolidated Financial Statements for the three and nine months ended September 30, 2026 and 2025
- · Exhibit 99.2: Management's Discussion and Analysis for the three and nine months ended September 30, 2026
- · Exhibit 99.3: CEO Certification of Interim Filings for quarter ended September 30, 2026
- · Exhibit 99.4: CFO Certification of Interim Filings for quarter ended September 30, 2026
- · Exhibit 99.5: News Release dated November 4, 2026
- · Principal executive offices located at Suite 1020, 400 Burrard Street, Vancouver, British Columbia V6C 3A6, Canada
- · Signed November 4, 2026 by Marius van Niekerk, EVP and CFO
05-11-2026
Sun Life Financial Inc. filed a Form 6-K on November 5, 2026, attaching a press release dated November 4, 2026, announcing its Third Quarter 2026 results. The filing itself contains only the cover page and signature (by Kevin Armitage, AVP & Managing Counsel, Corporate Legal); the substantive Q3 2026 financial figures are referenced in Exhibit 99.1 but not included in the provided text, so no revenue, earnings, or period-over-period comparisons can be quantified from this document.
- · Filing is a Form 6-K under Rule 13a-16/15d-16 of the Securities Exchange Act of 1934
- · Commission File Number: 001-15014
- · Registrant files annual reports under Form 40-F (not Form 20-F)
- · Principal executive offices: 1 York Street, 31st Floor, Toronto, Ontario M5J 0B6
- · Filing covers the month of November 2026; report signed November 4, 2026
- · Exhibit 99.1 is the press release titled 'Sun Life Reports Third Quarter 2026 Results' dated November 4, 2026 — actual Q3 2026 financial figures are not included in the provided text
05-11-2026
Sun Life Financial Inc. filed a Form 6-K for November 2026 referencing its Q3 2026 Shareholders' Report (Exhibit 99.1), CEO/CFO certifications under Canadian NI 52-109 (Exhibit 99.2), and an Earnings Coverage Ratio disclosure under NI 44-102 for shelf distributions (Exhibit 99.3). The filing wrapper itself contains no financial figures, so no period-over-period performance metrics can be assessed from the provided text.
- · Filing is a Form 6-K wrapper; substantive financial data resides in Exhibit 99.1 Shareholders' Report, which was not included in the provided text
- · Registrant files annual reports under Form 40-F (not Form 20-F)
- · Commission File Number: 001-15014
- · Exhibit 99.2 contains CEO and CFO certifications under Canadian National Instrument 52-109
- · Exhibit 99.3 contains Earnings Coverage Ratio pursuant to Canadian National Instrument 44-102 (Shelf Distributions)
- · Report signed November 4, 2026; filing covers the month of November 2026
- · Principal executive offices: 1 York Street, 31st Floor, Toronto, Ontario M5J 0B6
05-11-2026
Sun Life Financial Inc. filed a Form 6-K on November 5, 2026, disclosing a news release dated November 4, 2026 as Exhibit 99.1. The filing itself contains no financial figures, results, or performance data — only the cover page and signature by Kevin Armitage (AVP & Managing Counsel, Corporate Legal). No period-over-period metrics are available to assess.
- · Filing is a Form 6-K under Rule 13a-16/15d-16; registrant files annual reports on Form 40-F
- · Commission File Number: 001-15014
- · Exhibit 99.1 is a news release dated November 4, 2026 (content not included in the filing text)
- · Principal executive offices: 1 York Street, 31st Floor, Toronto, Ontario, M5J 0B6
- · Filing signed November 4, 2026
05-11-2026
Trekor Metals Limited (filed under the TASEKO MINES LTD / TGB ticker) submitted a Form 6-K on November 5, 2026, furnishing its interim financial statements and Management's Discussion and Analysis for the period ended September 30, 2026. The filing itself contains only cover-page and signature information, with the substantive financials attached as Exhibits 99.1 and 99.2, so no specific revenue, earnings, or period-over-period figures are disclosed in the filing text. CFO Bryce Hamming signed the report on November 4, 2026.
- · Interim financial statements cover the period ended September 30, 2026 (Exhibit 99.1)
- · Management's Discussion and Analysis covers the period ended September 30, 2026 (Exhibit 99.2)
- · Registrant files annual reports under Form 40-F (not Form 20-F)
- · Commission File Number: 001-31965
- · Principal executive offices: 12th Floor - 1040 West Georgia St., Vancouver, BC, V6E 4H1
- · Report signed November 4, 2026 and filed November 5, 2026
05-11-2026
Taseko Mines Ltd (filed under the name 'Trekor Metals Limited') submitted a Form 6-K on November 5, 2026, attaching a press release dated November 4, 2026 (Exhibit 99.1). The filing itself contains no financial figures, operational metrics, or period-over-period comparisons — only the cover page and signature of President Stuart McDonald. The substantive content resides in the referenced press release, which was not included in the provided text.
- · Filing is a Form 6-K (foreign private issuer report) under Rule 13a-16/15d-16
- · Registrant files annual reports under Form 40-F (not 20-F)
- · Commission File Number: 001-31965
- · Principal executive office: 12th Floor - 1040 West Georgia St., Vancouver, BC, V6E 4H1
- · Exhibit 99.1 is a press release dated November 4, 2026 — its contents were not provided in the filing text
- · Registrant name in filing appears as 'Trekor Metals Limited' (English translation), inconsistent with Taseko Mines Ltd
05-11-2026
United Breweries Co Inc (CCU) reported 9M 2026 net sales of ThCh$2,187,704,835, up 6.4% YoY from ThCh$2,056,212,344, with Q3 net sales rising 15.4% YoY to ThCh$760,388,280. However, 9M net income fell 22.9% YoY to ThCh$54,741,312 (EPS down to Ch$133.73 from Ch$167.94) as income tax benefit shrank to ThCh$4,896,777 from ThCh$44,977,664 and finance income dropped 42.2%; Q3 net income also declined 21.8% YoY to ThCh$16,174,716 despite higher sales.
- · Distribution costs rose 8.3% YoY to ThCh$427,774,010 (9M 2026) from ThCh$395,062,324, outpacing sales growth.
- · Administrative expenses increased 9.4% YoY to ThCh$166,421,903 from ThCh$152,068,609.
- · Cost of sales rose 5.3% YoY to ThCh$1,218,196,384 from ThCh$1,157,263,306.
- · Share of net loss of joint ventures and associates narrowed to ThCh$(7,912,457) from ThCh$(12,940,111).
- · Other gains (losses) improved to ThCh$(2,670,237) from ThCh$(12,722,510).
- · Total other comprehensive income swung to ThCh$149,828,577 from ThCh$(17,183,193), driven by exchange differences on translation of ThCh$158,018,954.
- · Comprehensive income rose to ThCh$204,569,889 from ThCh$53,777,904.
- · Inventories increased to ThCh$460,592,506 from ThCh$424,300,960 at Dec 31, 2025.
- · Property, plant and equipment (net) rose to ThCh$1,537,914,823 from ThCh$1,460,212,852.
- · Non-current other financial liabilities increased to ThCh$1,059,694,003 from ThCh$1,040,783,534.
- · Equity decreased by ThCh$165,036,004 through changes in ownership interests in subsidiaries, with ThCh$140,525,348 charged to other reserves.
05-11-2026
American Ventures Acquisition Corp. I filed Amendment No. 1 to its Form S-1 (Registration No. 333-296656) on November 4, 2026, for an initial public offering of a blank-check company incorporated in Florida and based in Jupiter, FL. The filing details redemption mechanics for public stockholders upon a future business combination, with the trust account initially anticipated to hold $5.00 per public share, and restricts redemptions to 15% of shares sold in the offering absent company consent. No pricing, share count, or gross proceeds figures were disclosed in the excerpt, so the offering size remains undetermined.
- · Company is a blank-check entity under SIC code 6770, incorporated in Florida, EIN 413533528, fiscal year end 1231
- · SEC file number 333-296656; film number 261523958; accession number 0001213900-26-116032
- · Business address: 110 Front Street, Suite 300, Jupiter, FL 33477; phone 212.393.4504
- · Sponsor, initial stockholders, directors, officers and advisory board members have agreed to waive redemption rights on founder and private shares
- · Redemptions may be conducted via tender offer (Rule 13e-4/Regulation 14E) or proxy solicitation (Regulation 14A) at company discretion
- · Business combination requires majority of votes cast if stockholder approval is sought; quorum is majority of votes entitled to be cast
- · If public stockholders tender more shares than offered, the tender offer will be withdrawn and the business combination not completed
- · Any Rule 10b5-1 purchase plans will be terminated upon announcement of a business combination to comply with Rule 14e-5
- · Purchases by sponsor/insiders outside the redemption offer may reduce public float and number of beneficial holders, potentially impairing exchange listing
- · No offering price, share count, or gross proceeds disclosed in this excerpt
05-11-2026
Non Invasive Monitoring Systems Inc (NIMU) filed an amended S-1 registration statement (S-1/A) on November 5, 2026, tied to a merger agreement with Gravitics Inc dated March 6, 2026 and amended August 5, 2026. The filing discloses a complex capital structure including Series Seed and Series A redeemable convertible preferred stock, Series B preferred stock, and multiple related-party promissory notes with Frost Gamma Investments Trust and Dr. Jane Hsiao, plus a convertible promissory note issued June 24, 2026. The XBRL-tagged filing contains no income statement or revenue figures in the extracted content, so period-over-period financial performance cannot be assessed from this data.
- · Merger Agreement between NIMU and Gravitics Inc dated March 6, 2026, with a subsequent amendment dated August 5, 2026
- · Convertible promissory note issued under a Note Purchase Agreement on June 24, 2026
- · New Promissory Note Agreement with Dr. Jane Hsiao dated May 7, 2026
- · Related-party promissory notes with Frost Gamma Investments Trust dated across 2023-2026 (Aug 15 2023, Sep 25 2024, Oct 23 2024, Jan 23 2025, Aug 27 2025, Jan 5 2026)
- · Subsequent event dated July 27, 2026 disclosed in the filing
- · Fiscal year end appears to be July 31 (periods ending 2024-07-31, 2025-07-31)
- · No revenue, net income, or cash flow figures were present in the extracted filing content
05-11-2026
Non Invasive Monitoring Systems Inc (NIMU) filed an S-4/A registration statement tied to a March 6, 2026 merger agreement with Gravitics Inc., with a subsequent amendment dated August 5, 2026. The filing is dominated by XBRL tagging of balance-sheet and equity data across multiple periods (2023-2026) rather than narrative financial results, so no revenue or earnings figures are disclosed in the extract. Related-party financing is a recurring theme, including promissory notes with the Frost Gamma Investments Trust and Dr. Jane Hsiao and a June 24, 2026 convertible promissory note purchase agreement.
- · Merger agreement between NIMU and Gravitics Inc. dated March 6, 2026, with a subsequent-event reference dated August 5, 2026
- · Convertible promissory note purchase agreement dated June 24, 2026
- · New promissory note agreement with Dr. Jane Hsiao dated May 7, 2026
- · Related-party promissory notes with Frost Gamma Investments Trust spanning 2023-2026, including a subsequent event dated January 5, 2026
- · Filing covers comparative periods from fiscal 2023 through the six months ended June 30, 2026
- · Preferred stock classes referenced include Series Seed, Series A, and Series B redeemable convertible preferred stock
06-11-2026
Coca-Cola Europacific Partners plc announced the appointment of Sean Summers as an Independent Non-executive Director effective 1 December 2026, following a Nomination Committee-led search as part of Board succession planning. Summers is currently EVP, Retail Media and Chief Marketing Officer of Mercado Libre, with prior senior marketing roles at Twinings (Associated British Foods) and PepsiCo. The filing contains no financial results or monetary figures despite the preliminary 'Financial Results' classification.
- · Appointment effective date: 1 December 2026
- · Sean Summers has held senior roles at Mercado Libre since 2012
- · Summers held marketing roles at PepsiCo between 1996 and 2010
- · Summers is an Independent Non-executive Board member of World Rugby
- · Summers holds an MBA from the Stanford Graduate School of Business
- · CCEP is a constituent of the NASDAQ 100 and FTSE 100 indices
- · CCEP ISIN: GB00BDCPN049; SEC Commission File Number 001-37791
- · No further disclosure required under UK Listing Rule 6.4.8 R
06-11-2026
Alphabet Inc. filed its Q3 2026 13F-HR disclosing 31 equity positions valued at a combined $88,346,124,056 as of September 30, 2026, with the largest holdings being SpaceX Class A ($55.5B), Planet Labs ($35.2B), and Arm Holdings ($19.6B). The portfolio is heavily concentrated in a handful of private/space and life-sciences names, while several positions are comparatively small, including Freshworks split across three share classes and minor stakes in Oscar Health and Sana Biotechnology. The filing reflects Alphabet's venture/investment arm holdings rather than operating results, so no period-over-period performance metrics are disclosed.
- · Portfolio is highly concentrated: SpaceX ($55.5B) and Planet Labs ($35.2B) together account for roughly 99% of total reported value.
- · Freshworks is held across three separate Class A line items totaling about $143.4M.
- · Neutron Holdings is reported in two line items totaling about $19.0M.
- · Filing signed by Marsida Saraci, VP, Corporate Controller and Principal Accounting Officer, on 11-05-2026.
- · Report period is 09-30-2026; filing date 11-06-2026.
- · Other included managers listed: GV Management Company, Google LLC, CapitalG II LP, and XXVI Holdings Inc.
06-11-2026
Marten Transport reported Q3 2026 operating revenue of $223.2M, up 1.3% YoY from $220.5M, with net income rising 30.7% to $2.9M ($0.04 EPS vs $0.03). However, nine-month revenue fell 3.4% to $650.3M and net income dropped 29.9% to $9.6M ($0.12 vs $0.17 EPS), while operating income declined 36.9% to $11.6M. Segment performance was mixed: Truckload revenue grew 11.9% in Q3 but posted a $0.2M operating loss, Dedicated revenue was flat (+0.3%) with operating income down 63.6%, and the Intermodal segment was fully discontinued (zero revenue vs $9.9M prior year).
- · Q3 2026 operating ratio was 98.6% (98.3% net of fuel surcharges); Truckload segment operating ratio was 100.2%, Dedicated 98.1%, Brokerage 94.8%
- · Truckload segment posted a Q3 operating loss of $0.2M versus a $2.0M loss in Q3 2025; nine-month Truckload operating income was $1.3M vs $0.04M prior year
- · Brokerage operating income rose to $2.0M in Q3 2026 from $1.6M, but fell to $5.0M for nine months from $6.5M
- · Fuel and fuel taxes expense jumped 47.1% YoY in Q3 to $49.3M, driven by higher fuel surcharge revenue ($23.3M Truckload vs $14.7M)
- · Nine-month cash from operations fell to $83.3M from $87.9M; capital expenditures on revenue equipment dropped to $64.7M from $121.7M
- · Cash and equivalents more than doubled to $91.5M from $43.3M at year-end 2025; total cash including escrow was $96.5M
- · Dividends declared of $0.06 per share in Q3; $0.18 per share for nine months, unchanged YoY
- · Retained earnings declined to $707.0M from $712.0M at Dec 31, 2025 despite net income, due to $14.7M in dividend payments
- · Nine-month insurance and claims expense fell 17.0% to $33.7M from $40.6M
06-11-2026
K&F Growth Acquisition Corp. II filed an 8-K disclosing a special resolution amending its Amended and Restated Memorandum and Articles of Association to extend the definition of the 'Completion Window' to thirty (30) months after the IPO closing date, now ending 6 August 2027. The amendment gives the SPAC additional time to complete an initial business combination, with the window still subject to earlier approval by the Directors or later extension by Members in accordance with the Articles. No financial terms, transaction counterparty, or merger target was disclosed in the excerpt.
- · Completion Window now ends 6 August 2027, thirty (30) months after the IPO closing date
- · The window may be shortened earlier by the Directors or extended later by the Members in accordance with the Articles
- · Amendment was effected by special resolution replacing the existing definition in Article 1.1
- · Filing items include 1.01 (Material Agreement Entry), 5.03 (Amendments to Articles), 5.07 (Submission of Matters to a Vote of Security Holders), and 9.01 (Financial Statements and Exhibits)
06-11-2026
EVERTEC entered an amended and restated credit agreement extending its approximately $388 million Term Loan A for up to five years and repricing it 25 basis points lower, while the revolving credit facility was also extended, repriced 25 basis points lower, and upsized from $200 million to $300 million. The transaction lowers borrowing costs and extends maturities, though it increases total revolver capacity and potential leverage. Truist Bank serves as administrative and collateral agent, with six joint lead arrangers.
- · Term Loan A maturity extended for up to five years
- · Revolving credit facility also extended and repriced 25 basis points lower
- · Truist Bank acted as administrative agent and collateral agent
- · Six banks acted as joint lead arrangers: Truist Securities, Banco Popular de Puerto Rico, Citizens Bank, FirstBank Puerto Rico, Fifth Third Bank, and The Huntington National Bank
- · EVERTEC operates across 29 countries and territories
- · Forward-looking statements reference 10-K for fiscal year ended December 31, 2025 filed March 2, 2026
06-11-2026
On November 6, 2026, X Financial's (NYSE: XYF) board received a preliminary non-binding proposal from Mangrove Coast Investment Limited, affiliated with Chairman and CEO Yue (Justin) Tang, to acquire all outstanding ordinary shares not beneficially owned by Mangrove at US$1.005 per ordinary share, or US$6.03 per ADS (each ADS representing six Class A ordinary shares). Mangrove already holds approximately 93.45% of total voting power, leaving a small public float subject to the buyout; the Board has not yet evaluated the proposal, intends to form an independent special committee with independent financial and legal advisors, and Tang will recuse himself. No definitive offer or agreement is assured.
- · Proposal letter is dated November 6, 2026 and attached as Exhibit 99.1
- · Mangrove is acquiring only shares it does not already beneficially own, implying a minority squeeze-out of the public float
- · Mr. Tang is affiliated with Mangrove and will recuse himself from Board deliberations and decisions on the proposal
- · Board cautions it has just received the letter and has not had an opportunity to review or evaluate the proposal
- · No assurance that a definitive offer will be made, an agreement executed, or the transaction approved or consummated
- · Company files annual reports under Form 20-F; SEC commission file number 001-38652
06-11-2026
Tampa Electric Company reported Q3 2026 net income of $217M, down 1.4% from $220M in Q3 2025, despite electric revenues declining 3.0% to $893M from $921M. For the nine-month period, net income rose 2.9% to $537M on revenue growth of 6.1% to $2,557M, while operating cash flow surged 69.5% to $1,071M. However, quarterly results were pressured by a 35.8% jump in fuel expense to $205M and higher interest charges, offset by a 26.9% drop in O&M expenses to $163M and lower purchased power costs of $15M versus $53M a year earlier.
- · Q3 2026 income from operations rose to $305M from $300M despite lower revenue, as total expenses fell to $588M from $621M
- · Nine-month 2026 total expenses rose to $1,789M from $1,685M, with fuel up to $515M from $394M
- · Q3 2026 interest expense increased to $62M from $59M; nine-month interest expense rose to $186M from $171M
- · Nine-month 2026 depreciation and amortization increased to $405M from $374M
- · Utility plant at original cost grew to $16,900M from $15,787M at year-end 2025
- · Accrued taxes rose sharply to $93M at September 30, 2026 from $14M at December 31, 2025
- · Nine-month 2026 net short-term debt increase of $112M versus a $126M decrease in 2025; no long-term debt issued in 2026 versus $593M in 2025
- · Pension net periodic benefit cost rose to $7M in Q3 2026 from $2M, including a $4M curtailment cost
06-11-2026
Passage Bio stockholders approved all proposals at the November 5, 2026 Special Meeting related to the merger with Remix Therapeutics, including issuance of Passage Bio shares to Remix securityholders (change of control under Nasdaq Rules 5635(a)/(b)), a reverse stock split of 1-for-2 to 1-for-10, and renaming the company to 'Remix Therapeutics, Inc.' The 2026 Equity Incentive Plan (5,772,500 shares reserved) and 2026 ESPP (440,000 shares) were also approved. However, support was notably weaker on equity plan proposals — Proposal 5 (2026 EIP) drew 458,604 votes against (~25% of votes cast) and Proposal 6 (ESPP) passed with only 1,383,770 for versus 458,604 against, while charter governance changes (4D, 4H) also saw meaningful opposition (~355,000-363,000 against).
- · Proposal 1 (share issuance to Remix holders): 1,806,227 for, 36,404 against, 553 abstaining, 475,637 broker non-votes
- · Proposal 2 (Reverse Stock Split 1-for-2 to 1-for-10): 2,202,453 for, 113,608 against, 2,760 abstaining
- · Proposal 3 (rename to Remix Therapeutics, Inc.): 1,809,243 for, 33,290 against, 651 abstaining
- · Proposal 4D (supermajority bylaw requirement): 1,479,152 for vs 363,438 against — largest opposition among charter proposals
- · Proposal 4H (supermajority for enumerated charter provisions): 1,485,412 for vs 355,992 against
- · Proposal 6 (2026 ESPP): 1,383,770 for vs 458,604 against
- · Merger Agreement dated September 2, 2026, amended October 5, 2026
- · Proxy Statement/Prospectus filed October 9, 2026; Record Date September 30, 2026
- · 2026 Plan annual increase runs January 1, 2027 through January 1, 2036
- · Passage Bio is a remote-only company with no headquarters; stockholder communications directed to P.O. Box 7, Hopewell, New Jersey 08525
06-11-2026
NetEase, Inc. filed a Form 6-K disclosing that it submitted a Next Day Disclosure Return to The Stock Exchange of Hong Kong Limited dated November 3, 2026, covering movements in authorized issued shares or treasury shares related to certain events. The filing is a routine share-movement disclosure and contains no financial results, revenue, or earnings figures. No quantitative amounts, percentages, or period comparisons were provided in the filing text.
- · Next Day Disclosure Return dated November 3, 2026 was submitted to The Stock Exchange of Hong Kong Limited
- · Disclosure relates to movements in authorized issued shares or treasury shares
- · Form 6-K filed for the month of November 2026 under Commission File Number 000-30666
- · Registrant files annual reports under Form 20-F
- · Principal executive offices listed at Room 802, 8/F, China Life Centre Tower A, One HarbourGate, No. 18 Hung Luen Road, Kowloon, Hong Kong
06-11-2026
Sylvamo Corporation announced on November 6, 2026 that it entered a put option agreement with Midas Atlantic Partners, in partnership with The Najafi Companies, for a binding offer to acquire Sylvamo's Europe business. Under the structure, the business transfers to Midas Atlantic Partners with an agreed level of working capital and cash in exchange for the right to receive 20% of future distributions of the business. The deal is not final — it requires works council and employee representative consultations, followed by a definitive share purchase agreement, with closing expected by the end of Q1 2027.
- · Transaction structure: Europe business transferred with an agreed level of working capital and cash, in exchange for the right to receive 20% of future distributions of the business
- · No purchase price or monetary consideration was disclosed in the filing
- · Closing expected by the end of the first quarter of 2027
- · Completion is conditioned on works council and employee representative consultations, regulatory approvals, and other closing conditions
- · Filing furnished under Item 7.01 (Regulation FD) and Item 9.01, with press release attached as Exhibit 99.1
- · Common stock trades on NYSE under ticker SLVM; commission file number 001-40718
06-11-2026
Starry Sea Acquisition Corp (SSEA) deposited $60,000 into its trust account on November 3, 2026, extending its deadline to consummate its initial business combination by one month from November 7, 2026 to December 7, 2026. The extension payment was loaned by SuperiorMed Healthcare, an affiliate of merger target SuperiorMed Holdings Limited, under the previously announced August 22, 2026 Merger Agreement. The deal remains subject to shareholder approval and regulatory approvals, with a Form F-4/S-4 registration statement still to be filed and declared effective.
- · Merger Agreement dated August 22, 2026 involves a two-step structure: SSEA merges into Purchaser (SuperiorMed Healthcare Group), and Merger Sub merges into SuperiorMed Holdings Limited
- · SuperiorMed Healthcare Management FZ-LLC is a Dubai free-zone limited liability company party to the transaction
- · The $60,000 loan from SuperiorMed Healthcare will be evidenced by a promissory note to be filed as an exhibit to a Form 8-K
- · Transaction requires a registration statement on Form F-4 or S-4 including proxy statement/prospectus, which must be declared effective before the shareholder vote
- · SSEA is an emerging growth company incorporated in the Cayman Islands (Commission File Number 001-42768)
- · Rights entitle holders to acquire one-sixth of one Ordinary Share each
06-11-2026
HSBC Holdings plc filed Amendment No. 1 to its Schedule TO on November 6, 2026, increasing the Maximum Tender Amount of its issuer tender offer for its 6.000% Perpetual Subordinated Contingent Convertible Securities (Callable May 22, 2027 and every five years thereafter) from $1,000,000,000 to $1,500,000,000 aggregate principal amount — a 50% increase. The offer, launched November 5, 2026, is a cash purchase under Rule 13e-4 and remains subject to the terms of the Offer to Purchase, with HSBC retaining the right to further increase or decrease the Maximum Tender Amount. No pricing, participation, or results data was disclosed in this amendment.
- · Securities are callable May 22, 2027 and every five years thereafter
- · Offer launched November 5, 2026; amendment filed November 6, 2026
- · HSBC retains the right to further increase or decrease the Maximum Tender Amount
- · Board resolutions relating to liability management adopted February 12, 2026
- · Indenture dated August 1, 2014; Fifth Supplemental Indenture dated May 22, 2017
- · Offer conducted under Rule 13e-4 (issuer tender offer); not a cross-border tender offer
06-11-2026
Castellum reported Q3 2026 revenue of $14.7 million, up just 0.7% YoY from $14.6 million but up 5.8% QoQ from $13.9 million, while 9M 2026 revenue grew 6% to $42.9 million from $40.3 million. However, gross profit fell to $5.3 million (36% margin) from $5.5 million (38%) in Q3 2025, Adjusted EBITDA dropped to ~$0.6 million from $1.1 million YoY, and the company swung to a net loss of $(0.5) million from net income of $0.4 million a year ago. Total backlog declined to $254.5 million from $271.7 million at June 30, 2026, though the qualified opportunity pipeline surged to ~$1.662 billion from $953.5 million, and the balance sheet remains debt-free with $15.7 million cash and $24.5 million in cash plus receivables.
- · Q3 2026 gross margin compressed to 36% from 38% YoY, driven by higher mix of lower-margin subcontractor work
- · Total backlog of $254.5 million consisted of only $18.2 million funded and $236.3 million unfunded
- · Backlog reporting was refined to include priced contract options previously reported separately within unfunded backlog
- · Company expects to recognize ~25% of remaining performance obligations within 12 months and ~51% within 24 months
- · Operating cash flow turned positive at $1.1 million in 9M 2026 versus $1.3 million used in 9M 2025
- · Combined cash and accounts receivable increased by an average of $0.5 million per quarter in 2026
- · Derivative liability fell to $10,000 from $262,000 at December 31, 2025; related-party notes payable of $400,000 were eliminated
- · Goodwill held flat at $10,676,834; intangible assets declined to $4,457,964 from $5,371,602
- · Company expects record full-year 2026 revenue
- · Management sees M&A as principal path to accelerate growth over the next 6 to 12 months
06-11-2026
Starry Sea Acquisition Corp (SSEA) deposited $60,000 into its IPO trust account on November 3, 2026, extending its deadline to consummate an initial business combination by one month, from November 7, 2026 to December 7, 2026. The extension payment was loaned to the company by SuperiorMed Healthcare, an affiliate of merger target SuperiorMed, and a promissory note is expected to be issued. The deposit relates to the previously announced August 22, 2026 Merger Agreement for a business combination with SuperiorMed Holdings Limited, under which SSEA will merge into Purchaser and Merger Sub will merge into SuperiorMed.
- · Extension deadline moved from November 7, 2026 to December 7, 2026
- · Merger Agreement originally entered into on August 22, 2026
- · SSEA will merge with and into Purchaser, with Purchaser surviving as the publicly traded entity
- · Merger Sub will merge with and into SuperiorMed, with SuperiorMed surviving as a wholly-owned subsidiary of Purchaser
- · Company is a Cayman Islands exempted company incorporated with file number 001-42768
- · Registration Statement on Form F-4 or S-4 including proxy statement/prospectus still to be filed with the SEC
- · Company qualifies as an emerging growth company
- · IPO prospectus dated August 7, 2025
Get daily alerts with 13 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Pre-Market SEC Filings Roundup
🇺🇸 More from United States
View all →November 07, 2026
General Federal Contracts — November 07, 2026
General Federal Contracts
November 07, 2026
High-Value Federal Grants ($5M+) — November 07, 2026
High-Value Federal Grants ($5M+)
November 07, 2026
Contract Deobligations Alert — November 07, 2026
Contract Deobligations Alert
November 07, 2026
Significant Contract Modifications ($10M+) — November 07, 2026
Significant Contract Modifications ($10M+)